In terms of radiotherapy-induced antitumor immunity, vancomycin has been demonstrated to enhance radiotherapy-induced antitumor immunity and suppress tumor growth, a synergistic effect dependent on cross-presentation of tumor antigens to CD8+ T cells and IFN-γ signaling. Here, CD8A is linked to neoplasm.